Ir para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Bioequivalence study of abacav...
  • Citar
  • Enviar por SMS
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Permanent link
Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions

Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions

Detalhes bibliográficos
Main Authors: Ekawan Yoosakul, Jaturavit Vattanarongkup, Chutima Manamuti, Bancha Chuasuwan, Isariya Techatanawat, Busarat Karachot, Porranee Puranajoti
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2016-02-01
Colecção:Asian Journal of Pharmaceutical Sciences
Assuntos:
Abacavir
Lamivudine
Bioequivalence
LC-MS/MS
Pharmacokinetics
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1818087615001828
  • Exemplares
  • Descrição
  • Registos relacionados
  • Registo fonte

Internet

http://www.sciencedirect.com/science/article/pii/S1818087615001828

Registos relacionados

  • Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
    Por: Saye H. Khoo, et al.
    Publicado em: (2011-06-01)
  • Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
    Por: Hardik Chandasana, et al.
    Publicado em: (2024-07-01)
  • Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
    Por: Torsak Bunupuradah, et al.
    Publicado em: (2015-07-01)
  • Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
    Por: Bagella P, et al.
    Publicado em: (2019-05-01)
  • The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection
    Por: A V Kravchenko, et al.
    Publicado em: (2014-11-01)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs